肝移植候选伴肾功能不全者行肝肾联合移植:肌酐水平、透析与器官质量对生存的重要性
基于美国移植受者科学登记系统2003至2013年成人受者数据,比较肝肾联合移植(SLK)与单纯肝移植(LTA)在中度肾功能不全人群的生存获益。倾向评分匹配后,SLK在四组中均降低移植后死亡风险,但仅在移植时未透析且血肌酐≥2 mg/dL组达统计学显著(HR 0.77;95%CI 0.62-0.96)。移植前透析暴露与供体质量影响SLK受者总体生存。
要点
- 移植时未透析且血肌酐≥2 mg/dL者,SLK较LTA降低死亡风险(HR 0.77;95%CI 0.62-0.96)。
- 该组患者年死亡率SLK为5.7%,LTA为7.6%(p=0.005)。
- 供体质量较好(L-DRI<1.5)的SLK受者中观察到死亡率下降。
核心结论
- 移植前透析暴露与供体质量影响肝肾联合移植受者的总体生存。
- 在移植时未透析且血肌酐≥2 mg/dL的受者中,SLK较LTA显著降低移植后死亡风险(HR 0.77;95%CI 0.62-0.96)。
研究设计与样本
- 基于美国移植受者科学登记系统(Scientific Registry of Transplant Recipients)的队列研究,纳入2003至2013年间接受单纯肝移植(N=2,700)或肝肾联合移植(N=1,361)的成人中度肾功能不全受者。
- 按登记时和移植时血肌酐(<2 mg/dL vs ≥2 mg/dL)及透析状态分为四组。
- 排除移植前需急性透析超过3个月的终末期肾病患者。
- 在各分层组内进行倾向评分匹配,以减少SLK与LTA间协变量分布不平衡及测量混杂。
- 供体质量以肝供体风险指数(L-DRI)评估,主要结局为移植后死亡。
主要发现
- 在多变量倾向评分匹配的Cox比例风险模型中,SLK在全部四组中均较LTA降低移植后死亡风险,但仅在移植时未透析且血肌酐≥2 mg/dL组达统计学显著(HR 0.77;95%CI 0.62-0.96)。
- 上述组患者年死亡率SLK为5.7%,LTA为7.6%(p=0.005)。
- 在供体质量较好(L-DRI<1.5)的SLK受者中观察到死亡率下降。
关键数值与推荐
- 移植时未透析且血肌酐≥2 mg/dL组:SLK较LTA的移植后死亡HR 0.77(95%CI 0.62-0.96)。
- 该组患者年死亡率SLK为5.7%,LTA为7.6%(p=0.005)。
- 供体质量较好定义为L-DRI<1.5。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The survival benefit from simultaneous liver-kidney transplantation (SLK) over liver transplant alone (LTA) in recipients with moderate renal dysfunction is not well understood. Moreover, the impact of deceased donor organ quality in SLK transplant survival has not been well described in the literature. METHODS: The Scientific Registry of Transplant Recipients was studied for adult recipients receiving LTA (N=2,700) or SLK (N=1,361) transplantation with moderate renal insufficiency between 2003 and 2013. The study cohort was stratified into four groups based on serum creatinine (Scr< 2 mg/dL versus Scr≥ 2 mg/dL) and dialysis status at listing and at transplant. The patients with end-stage renal disease and requiring acute dialysis more than three months before transplantation were excluded. A propensity score (PS)-matching was performed in each stratified groups to factor out imbalances between the SLK and LTA regarding covariates distribution and to reduce measured confounding. Donor quality was assessed with liver-donor risk index (L-DRI). The primary outcome of interest was post-transplant mortality. RESULTS: On multivariable PS-matched Cox proportional hazard models, SLK led to decrease in post-transplant mortality compared to LTA across all four groups, but only reached statistical significance (HR 0.77; 95% CI, 0.62-0.96) in the recipients not exposed to dialysis and Scr≥ 2 mg/dL at transplant (mortality incidence rate per patient-year 5.7% in SLK vs. 7.6% in LTA, p=0.005). The decrease in mortality was observed among SLK recipients with better quality donors (L-DRI<1.5). CONCLUSIONS: Exposure to pre-transplantation dialysis and donor quality affected overall survival among SLK recipients.
引用
- Tanriover B, MacConmara MP, Parekh J, et al. SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL. Kidney Int Rep. 2016. PMID: 27942610. doi:10.1016/j.ekir.2016.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。